Kyle Dempsey
Director/Board Member at OPTINOSE, INC.
Net worth: 6 089 $ as of 2024-04-29
Profile
Dr. Kyle Dempsey is an Independent Director at HLS Therapeutics, Inc., an Independent Director at OptiNose, Inc. and a Partner at MVM Partners LLC.
He is on the Board of Directors at HLS Therapeutics, Inc., OptiNose, Inc. and GT Medical Technologies, Inc. He received his undergraduate degree from Bowdoin College, an MBA from Harvard Business School and a doctorate degree from Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HLS THERAPEUTICS, INC.
0.01% | 2024-03-30 | 1,765 ( 0.01% ) | 6 089 $ | 2024-04-29 |
OPTINOSE, INC.
-.--% | 2023-06-07 | 0 ( -.--% ) | - $ | 2024-04-29 |
Kyle Dempsey active positions
| Companies | Position | Start |
|---|---|---|
| OPTINOSE, INC. | Director/Board Member | 2021-12-09 |
| HLS THERAPEUTICS INC. | Director/Board Member | 2022-11-28 |
| MVM Partners LLC | Private Equity Investor | 2017-08-31 |
GT Medical Technologies, Inc.
 GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology GT Medical Technologies, Inc. engages in the design and development of a medical device for the treatment of brain tumors. It offers GammaTile Therapy, which is a surgically targeted radiation therapy which is placed at the end if a brain excision surgery and targets residual tumor cells. The company was founded by Heyoung McBride, Peter Nakaji, Emad Youssef, and Theresa Thomas in 2017 and is headquartered in Tempe, AZ. | Director/Board Member | - |
Training of Kyle Dempsey
| Bowdoin College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| HLS THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
| MVM Partners LLC | Finance |
GT Medical Technologies, Inc.
GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology GT Medical Technologies, Inc. engages in the design and development of a medical device for the treatment of brain tumors. It offers GammaTile Therapy, which is a surgically targeted radiation therapy which is placed at the end if a brain excision surgery and targets residual tumor cells. The company was founded by Heyoung McBride, Peter Nakaji, Emad Youssef, and Theresa Thomas in 2017 and is headquartered in Tempe, AZ. | Health Technology |
- Stock Market
- Insiders
- Kyle Dempsey
